Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Orexo AB via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Språk
Typ
Språk
Typ
2025-09-08 10:00:00
Seminar: IP That Matters - Behind Orexo’s Milestone Patent Win at the US Court – Sthlm event
Uppsala, Sweden – September 8, 2025 – Orexo (publ.), (STO:ORX) (OTCQX:ORXOY) and its advisory law firms Potter Clarkson LLP and Steptoe LLP have received strong interest for the seminar they will be co-hosting at this year’s Nordic Life Science Days’ conference in Gothenburg, Sweden, on October 13 (invitation published on August 29). However, due to the positive response from those not att...
2025-09-08 10:00:00
Seminarium: IP som gör skillnad – lärdomar från Orexos patentframgång i USA – Sthlm event
Uppsala, den 8 september 2025 – Orexo AB (publ) (STO:ORX) (OTCQX:ORXOY) och bolagets juridiska rådgivare Potter Clarkson LLP och Steptoe LLP har noterat ett stort intresse för seminariet de arrangerar tillsammans vid årets Nordic Life Science Days i Göteborg den 13 oktober (inbjudan publicerad 1 september). Därför kommer även eventet arrangeras i Stockholm den 15 oktober kl 17.30 på Bern...
2025-09-01 10:30:00
Seminarium: IP som gör skillnad – lärdomar från Orexos patentframgång i USA
Uppsala, den 1 september 2025 – Orexo AB (publ) (STO:ORX) (OTCQX:ORXOY) kommer i samarbete med sina juridiska rådgivare, Potter Clarkson LLP och Steptoe LLP, arrangera ett seminarium om utformningen av robusta patentstrategier för att skydda immateriella rättigheter inom läkemedelsindustrin, även vid fientlig generisk opposition. Seminariet riktar sig till innovatörer, läkemedels- och bio...
2025-08-29 13:30:00
Seminar: IP That Matters - Behind Orexo’s Milestone Patent Win at the US Court
Uppsala, Sweden – August 29, 2025 – Orexo (publ.), (STO:ORX) (OTCQX:ORXOY) in collaboration with its advisory international law firms Potter Clarkson LLP and Steptoe LLP, will host a seminar on how to build robust patent strategies that will protect pharmaceutical IP even in the face of hostile generic opposition. The session, targeting innovators, pharma companies, biotech firms and investors...
2025-07-10 09:00:00
Shaping the Future of Drug Delivery: Orexo’s AmorphOX® Unlocks New Possibilities for Critical Medicines
Formulating therapeutics as powders offers significant advantages over liquids, particularly for stabilizing fragile compounds that degrade under varying environmental conditions. This approach enhances molecular stability, extends shelf life, and eliminates the need for cold chain logistics. Orexo has emerged as a leader in the intranasal delivery of powder-based medications thanks to its proprie...
2024-12-13 10:00:00
Analytical chemist, Anneli Wennman on problem-solving from end-to-end
Anneli’s role spans everything from early stage concepting to interrogating solutions, blending chemistry with creative thinking and leadership with coaching. In this interview, Anneli reveals more about the variety in her role, digging into data and what she’s looking forward to in the year ahead. What does your role as a senior analytical chemist involve? It’s incredibly varied – I’m i...
2024-09-12 15:00:00
Opioid misuse and overdose in the aging population needs increased attention
OREXO NEWS ARTICLE: Uppsala, Sweden, September 12, 2024. Substance use disorders among older adults in the US rarely make the headlines, despite being a significant and growing public health concern, with rising rates of opioid overdose. [i] This article considers the reasons some older adults are misusing opioids and what needs to change. The baby boom generation, born between 1946 and 1965, are ...